Clinical trial
Evaluation of the Aurora Xi New Nomogram Software 2.0
NCT06122935 is registered in ClinicalTrials.gov with Fenwal, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Aurora Xi New Nomogram Software 2.0
- Lead sponsor
- Fenwal, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 27, 2023
- Completion date
- May 31, 2024
- Enrollment
- 6,735 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
apheresis related hypotension